Last reviewed: June 2, 2026

Last updated: June 2, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Yes, Ozempic (semaglutide) can be prescribed off-label for weight loss by licensed providers, though it is FDA-approved only for type 2 diabetes. Approximately 40% of adults with obesity who seek weight management support report prior interest in GLP-1 receptor agonists, yet eligibility and access vary significantly based on medical history, BMI, and comorbidities.

Getting a prescription involves a medical evaluation focused on metabolic risk factors and obesity-related health conditions. Understanding your individual eligibility—and exploring how genetic predispositions in peptide pathways may inform treatment selection—can help you and your provider identify the most appropriate weight management strategy.

Medical Eligibility Criteria for GLP-1 Weight Loss Prescriptions

Licensed providers typically prescribe GLP-1 receptor agonists like semaglutide for weight loss when patients meet specific criteria: BMI of 30 or higher, or BMI of 27+ with weight-related comorbidities such as hypertension, type 2 diabetes, or cardiovascular disease. A comprehensive medical history is essential to rule out contraindications, including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2.

Providers also evaluate baseline metabolic markers—fasting glucose, HbA1c, lipid panel, and kidney function—to ensure safe initiation and monitoring. This assessment helps determine not only if you qualify, but which formulation and dosing approach may be most suitable for your metabolic profile and treatment goals.

Prescription Pathways: Branded vs. Compounded GLP-1 Options

Patients seeking GLP-1 therapy have multiple pathways: branded medications (Wegovy, Ozempic, Mounjaro, Zepbound) through retail pharmacies, or compounded semaglutide and tirzepatide from licensed 503A compounding pharmacies. Each pathway carries different considerations around cost, insurance coverage, supply chain reliability, and personalization options such as genetic insights into peptide pathway predispositions.

Prescription Pathway Key Clinical & Access Features
Branded Ozempic/Wegovy FDA-approved, widely insured, pre-manufactured single-dose pens; established safety profile; potential shortage risk and higher out-of-pocket costs if uninsured.
Branded Mounjaro/Zepbound Dual-action GIP/GLP-1 agonist, FDA-approved for weight loss; stronger efficacy data in trials; limited insurance coverage; cost ~$1,000/month retail.
Compounded Semaglutide Licensed 503A pharmacy preparation; flexible dosing; more affordable pricing starting ~$149/month; requires provider oversight; no FDA brand approval for formulation.
Compounded Tirzepatide Dual-action GIP/GLP-1 compound; starting ~$249/month; flexible dosing; genetic insights may inform individual response predispositions; requires provider monitoring.

How Genetic Predispositions May Inform GLP-1 Treatment Selection

Emerging evidence suggests that variants in GLP-1 receptor (GLP1R), GIP receptor (GIPR), and metabolic genes (FTO, MC4R) may influence individual responsiveness to GLP-1 and dual-action therapies. Identifying your predispositions in these peptide pathways can help providers tailor initial medication choice and dosing strategy, potentially reducing trial-and-error and optimizing efficacy.

The Precision Peptide Genetic Test reveals predispositions in key peptide pathway variants and may help provide context for why certain GLP-1 formulations work better for some individuals than others. This insight—interpreted with your qualified healthcare provider—can support a more personalized conversation about whether semaglutide, tirzepatide, or dual-action compounds align with your genetic profile and metabolic goals.

Safety Considerations and Provider Monitoring During Treatment

GLP-1 medications slow gastric emptying and can cause nausea, vomiting, constipation, and rare pancreatitis. Serious but uncommon risks include thyroid C-cell tumors (animal data) and gallbladder issues. Absolute contraindications include personal history of medullary thyroid carcinoma, MEN2 syndrome, and severe renal impairment. Pregnancy and breastfeeding are also contraindications.

Ongoing provider oversight is critical: baseline and periodic kidney function tests, fasting glucose, HbA1c, and lipid panels help monitor efficacy and safety. If you experience persistent vomiting, severe abdominal pain, or signs of pancreatitis, contact your provider immediately. Regular follow-ups every 4-12 weeks ensure your dose is appropriate and side effects are manageable.

How PlexusDx Supports a More Personalized Approach

PlexusDx simplifies GLP-1 access through licensed 503A compounding pharmacies with flat-rate pricing that does not increase with dose—your dose may need to go up, your price won't. Beyond medication selection, PlexusDx offers genetic insights into peptide pathway predispositions (GIPR, GLP1R, FTO, MC4R variants) that may help provide context for why certain GLP-1 formulations work better for your unique metabolic profile.

The Precision Peptide Genetic Test is a $99 add-on (after first month of treatment) that reveals predispositions in key peptide signaling pathways linked to GLP-1 and GIP receptor responsiveness. This test does not predict exact medication response or guarantee outcomes; instead, it should be interpreted with your qualified healthcare provider as one clinical tool to inform personalized treatment strategy.

Understanding your genetic predispositions alongside medical history, comorbidities, and metabolic markers empowers you and your provider to make a more informed decision about which GLP-1 formulation—semaglutide, tirzepatide, or dual-action compound—aligns best with your individual physiology and treatment goals. This precision approach can support a more nuanced conversation about long-term adherence and efficacy.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Related Reading

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves